Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002533410 | SCV000770772 | likely benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004559310 | SCV002741200 | likely benign | Dyskeratosis congenita | 2022-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003437372 | SCV004153853 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | TERT: BP4, BP7 |
Prevention |
RCV004735716 | SCV005350977 | likely benign | TERT-related disorder | 2024-04-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |